No Data
No Data
Express News | Processa Pharmaceuticals Inc - on Feb 4, Received Nasdaq Notice for Bid Price Non-Compliance
Processa Pharmaceuticals to Present at the 2025 BIO CEO & Investor Conference
Favourable Signals For Processa Pharmaceuticals: Numerous Insiders Acquired Stock
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Insider Purchase: Pres. Research & Development of $PCSA Buys 124,500 Shares
Processa Pharmaceuticals Prices $5M At-the-market Offering